Safety of benzodiazepines in the geriatric population

Expert Opinion on Drug Safety

Volumn 3, Issue 5, 2004, Pages 485-493

  Madhusoodanan, Subramoniam ^a   Bogunovic, Olivera J ^b  

^a ST JOHN S EPISCOPAL HOSPITAL   (United States)

^b TLC Health Network   (United States)

Author keywords

Anxiety; Benzodiazepines; Drug dependents abuse; Elderly; Safety

Indexed keywords

ALCOHOL; ALPRAZOLAM; ANTACID AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CIMETIDINE; CLONAZEPAM; DIAZEPAM; DRUG METABOLITE; ERYTHROMYCIN; FLUOXETINE; HYPNOTIC SEDATIVE AGENT; KETOCONAZOLE; LONG ACTING DRUG; LORAZEPAM; METOPROLOL; NARCOTIC AGENT; NEFAZODONE; NORDAZEPAM; OXAZEPAM; PHENYTOIN; PSYCHOTROPIC AGENT; RANITIDINE; RIFAMPICIN; SHORT ACTING DRUG; TEMAZEPAM; TRIAZOLAM; UNINDEXED DRUG; VALPROIC ACID;

AGE; AMNESIA; ANTEROGRADE AMNESIA; ANXIETY DISORDER; BALANCE DISORDER; CLINICAL STUDY; COGNITIVE DEFECT; COMORBIDITY; COMPLICATION; CONFUSION; DELIRIUM; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRIVING ABILITY; DROWSINESS; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG HALF LIFE; DRUG INDICATION; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; ELDERLY CARE; EXPERIENCE; FALLING; FAMILY THERAPY; FATIGUE; FREQUENCY ANALYSIS; GAIT DISORDER; HIP FRACTURE; HUMAN; INSOMNIA; LONG TERM CARE; MENTAL DISEASE; NEUROTOXICITY; PHARMACODYNAMICS; POLYPHARMACY; POPULATION RESEARCH; PRESCRIPTION; PSYCHOMOTOR DISORDER; REVIEW; RISK FACTOR; SEDATION; SEX DIFFERENCE; SIDE EFFECT; TRAFFIC ACCIDENT; WITHDRAWAL SYNDROME;

AGED; AGING; ANTI-ANXIETY AGENTS; ANXIETY; BENZODIAZEPINES; BIOTRANSFORMATION; COGNITION DISORDERS; DRUG UTILIZATION; FEMALE; HALF-LIFE; HUMANS; LIVER; MALE; MENTAL DISORDERS; PSYCHOMOTOR PERFORMANCE; RISK; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 4544271512     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.5.485     Document Type: Review

References (75)

1. BAUM C, KENNEDY DL, FORBES MB, JONES JK: Drug use in the United States in 1981. JAMA (1984) 251(10):1293-1297.
2. THOMPSON TL II, MORAN MG, NIES AS: Drug therapy: psychotropic drug use in elderly (first of two parts). N. Engl. J. Med. (1983) 320(3):134-138.
3. VAN HULTEN R, ISACSON D, BAKKER A, LEUFKENS HG: Comparing patterns of long-term benzodiazepine use between a Dutch and a Swedish community. Pharmacoepidemiol. Drug Saf. (2003) 12(1):49-53.
4. LECHEVALLIER N, FOURRIER A, BERR C: [Benzodiazepine use in the elderly: the EVA Study.] Rev. Epidemiol. Sante Publique (2003) 51(3):317-326. French.
5. FOURRIER A, LETENNEUR L, DARTIGUES JF, MOORE N, BEGAUD B: Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur. J. Clin. Pharamacol. (2001) 57(5):419-425.
6. HOGAN DB, MAXWELL CJ, FUNG TS, EBLY EM: Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can. J. Clin. Pharmacol. (2003) 10(2):72-77.
7. JORM AF, GRAYSON D, CREASEY H, WAITE L, BROE GA: Long-term benzodiazepine use by elderly people living in the community. Aust. N Z J. Public Health (2000) 24(1):7-10.
8. EGAN M, MORIDE Y, WOLFSON C, MONETTE J: Long-term continous use of benzodiazepine by older adults in Quebec: prevalence, incidence and risk factors. J. Am. Geriatr. Soc. (2000) 48(7):811-816.
9. GOLDEN AG, PRESTON RA, BARNETT SD, LIORENTE M, HADMAN K, SILVERMAN MA: Inappropriate medication prescribing in homebound older adults. J. Am. Geriatr. Soc. (1999) 47(8):948-952.
10. GRAD R, TAMBLYN R, HOLBROOK AM, HURLEY J, FEIGHTNER J, GAYTON D: Risk of a new benzodiazepine prescription in relation to recent hospitalization. J. Am. Geriatr. Soc. (1999) 47(2):184-188.
11. LEIPZIG RM, CUMMING RG, TINETTI ME: Drugs and falls in older people: a systematic review and metaanalysis: I. Psychotropic drugs. J. Am. Geriatr. Soc. (1999) 47(1):30-39.
12. GLEASON PP, SCHULZ R, SMITH NL et al.: Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J. Gen. Intern. Med. (1998) 13(4):243-250.
13. HANLON JT, HORNER RD, SCHMADER KE et al.: Benzodiazepine use and cognitive function among community dwelling elderly. Clin. Pharmacol. Ther. (1998) 64(6):684-692.
14. HEMMELGARN B, SUISSA S, HUANG A, BOIVIN JF, PINARD G: Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA (1997) 278(1):27-31.
15. SPORE D, MOR V, HIRIS J, LARRAT EP, HAWES C: Psychotropic use among older residents of board and care facilities. J. Am. Geriatr. Soc. (1995) 43(12):1403-1409.
16. STEWART RB, MARKS RG, PADGETT PD, HALE WE: Benzodiazepine use in ambulatory elderly population: a 14 year overview. Clin. Ther. (1994) 16(1):118-124.
17. SEMLA TP, COHEN D, PAVEZA G et al.: Drug use patterns of persons with Alzheimers disease and related disorders living in the community. J. Am. Geriatr. Soc. (1993) 41(4):408-413.
18. MORGAN K, DALLOSSO H, EBRAHIM S, ARIE T, FENTEM PH: Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. Br. Med. J. (Clin. Res. Ed.) (1988) 296(6622):601-602.
19. LLORENTE MD, DAVID D, GOLDEN AG, SILVERMAN MA: Defining patterns of benzodiazepine use in older adults. J. Geriatr. Psychiatry Neurol. (2000) 13(3):150-160.
20. EGAN M, WOLFSON C, MORIDE J, MONETTE J: Do patient factors alter the relationship between physician characteristics and use of long acting benzodiazepines. J. Clin. Epidemiol. (2000) 53(11):1181-1187.
21. BEARDSLEY RS, LARSON DB, BURNS BJ, THOMPSON IW, KAMEROW DB: Prescribing of psychotropics in elderly nursing home patients. J. Am. Geriatr. Soc. (1989) 37(4):327-330.
22. ROVNER BW, EDELMAN B, COX M, SHUMELY Y: The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am. J. Psychiatry (1992) 149(10):1390-1392.
23. HOLMQUIST IB, SVENSSON B, HOGLUND P: Psychotropic drugs in nursing and old age homes: relationships between needs of care and mental health status. Eur. J. Clin. Pharmacol. (2003) 59:669-676.
24. NIELSON CP, CUSACK PJ, VESTAL RE: Geriatric clinical pharmacology and therapeutics. In: Avery's drug treatment: principles and practice of clinical pharmacology and therapeutics (3rd edn). Speight (Ed.), ADIS Press, Auckland, New Zealand (1987):160-193.
25. NOWELL PD, MAZUMDAR S, BUYSSE DJ, DEW MA, REYNOLDS CF III, KUPFER DJ: Benzodiazepines and zolpidem for chronic insomnia: a meta analysis of treatment efficacy. JAMA (1997) 278(4):2170-2177.
26. HOLBROOK AM, CROWTHER R, LOTTER A, CHENG C, KING D: Meta-analysis of benzodiazepine use in the treatment of insomnia. CAMJ (2000) 162:225-233.
27. MORIN CM, COLECCHI C, STONE J, SOOD R, BRINK D: Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA (1999) 281(11):991-999.
28. HOLBROOK AM, CROWTHER R, LOTTER A, CHENG C, KING D: The diagnosis and manangement in clinical practice: a practical evidence based approach. CMAJ (2000) 162:216-220.
29. SHEIKH J: Anxiety disorders. In: Comprehensive review of geriatric psychiatry. Jarvik LF, Grossberg GT (Eds), American Psychiatric Press, Washington, DC, USA (1996):620.
30. LENZE EJ, POLLOCK BG, SHEAR MK, MULSANT BH, BHARUCHA A, REYNOLDS CF III: Treatment consideration for anxiety in the elderly. CNS Spectr. (2003) 8(12 Suppl. 3):6-13.
31. BEERS M: Explicit criteria determining potentially inappropriate medication use by the elderly. Arch. Intern. Med. (1997)157:1531-1536.
32. SMALL GW, RABINS PV, BARRY PP et al.: Diagnosis and treatment of Alzheimer's disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatric Society. JAMA (1997) 278(16):1363-1371.
33. SOLOW C: Psychotropic drugs in somatic disorders. Int. J. Psychiatry Med. (1975) 6(1-2):267-282.
34. FERNANDEZ L, CASSAGNE-PINEL C: Benzodiazepine addiction and symptoms of anxiety and depression in elderly subjects. Encephale (2001) 27(5):459-474.
35. ROYAL COLLEGE OF PHYSICIANS: Medication for the elderly. J. R. Coll. Physicians Lond. (1984) 18(1):7-17.
36. BEEKMAN AT, DE BEURS E, VAN BALKOM AJ, DEEG DJ, VAN DYCK R, VAN TILBURG W: Anxiety and depression in later life: co-occurrence and community of risk factors. Am. J. Psychiatry (2000) 157(1):89-95.
37. CARLSTEN A, WAERN M, HOLMGREN P, ALLEBECK P: The role of benzodiazepines in elderly suicides. Scand. J. Public Health (2003) 31(3):224-228.
38. PARKER W: Effect of hospitalization on patient use of hypnotics. Am. J. Hosp. Pharm. (1983) 40(3):446-447.
39. PERRY S, WU A: Rationale for the use of hypnotic agents in a general hospital. Ann. Intern. Med. (1984) 100(3):441-446.
40. SURENDRAKUMAR D, DUNN M, ROBERTS CJ: Hospital admission and the start of benzodiazepine use. Br. Med. J. (1992) 304(6831):881.
41. ELLIOTT RA, WOODWARD MC, OBORNE CA: Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern. Med. J. (2001) 31:529-535.
42. RAMESH M, ROBERTS G: Use of night time benzodiazepines in an elderly inpatient population. J. Clin. Pharm. Ther. (2002) 27:93-97.
43. COOK PJ: Benzodiazepine hypnotics in the elderly. Acta Psychiatr. Scand. Suppl. (1986) 332:149-158.
44. SWIFT CG: Special problems relating to the use of hypnotics in the elderly. Acta Psychiatr. Scand. Suppl. (1986) 329:92-98.
45. PIES RW: Anxyolitics and sedative hypnotics. In: Handbook of Essential Psychopharmacology. Pies RW (Ed.), American Psychiatric Press Inc., Washington DC, USA (2001):211-282.
46. SALZMAN C, SHADER RI, GREENBLATT DJ, HARMATZ JS: Long versus short half-life benzodiazepine in the elderly. Arch. Gen. Psychiatry (1983) 40(3):293-297.
47. COOK PJ, HUGGETT A, GRAHAM-POLE R, SAVAGE IT, JAMES IM: Hypnotic accumulation and hangover in elderly inpatients: a controlled double blind study of temazepam and nitrazepam. Br. Med. J. (Clin. Res. Ed.) (1983) 286(6359):100-102.
48. GRYMONPRE RE, MITENKO PA, SITAR DS, AOKI FY, MONTGOMER PR: Drug-associated hospital admissions in older medical patients. J. Am. Geriatr. Soc. (1988) 36(12):1092-1098.
49. NO AUTHORS LISTED: Clinical depression of the central nervous system due to diazepam and chlordiazeperoxide in relation to cigarette smoking and age. N. Engl. J. Med. (1973) 288(6):277-280.
50. GREENBLATT DJ, KOCH-WESER J: Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: a report from the Boston Collaborative Surveillance Program. Eur. J. Clin. Pharmacol. (1974) 7(4):259-262.
51. GREENBLATT DJ, ALLEN MD: Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance program. Br. J. Clin. Pharmacol. (1978) 5(5):407-413.
52. POMARA N, DEPTULA D, MEDEL M, BLOCK RI, GREENBLATT DJ: Effects of diazepam on recall memory; relationship to aging, dose, and duration of treatment. Psychopharmacol. Bull. (1989) 25(1):144-148.
53. TATA PR, ROLLINGS J, COLLINS M, PICKERING A, JACOBSON RR: Lack of cognitive recovery following withdrawal from long-term use. Psychol. Med. (1994) 24(1):203-213.
54. PATERNITI S, DUFOUIL C, ALPEROVITCH A: Long term benzodiazepine use and cognitive decline in the elderly. The Epidemiology of Vascular Aging Study. J. Clin. Psychopharmacol. (2002) 22(3):285-293.
55. LARSON EB, KUKULL WA, BUCHNER D, REIFLER BV: Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann. Intern. Med. (1987) 107(2):169-173.
56. EISCH AJ, MANDYAM CD: Drug dependence and addiction, II: adult neurogenesis and drug abuse. Am. J. Psychiatry (2004) 161(3):426.
57. MARCANTONIO ER, JUAREZ G, GOLDMAN L et al.: The relationship of postoperative delirium with psychoactive medications. JAMA (1994) 272(19):1518-1522.
58. NEUTEL CI: Risk of traffic accident injury after a prescription for a benzodiazepine. Ann. Epidemiol. (1995) 5(13):239-244.
59. CUMMING RG, LE COUTEUR DG: Benzodiazepines and risk of hip fractures in older people. CNS Drugs (2003) 17:825-837.
60. FRANCES A: Substance related disorders. In: Diagnostic and statistical manual of mental disorders (4th edn). American Psychiatric Press, Washington DC, USA (1994).
61. FINLAYSON RE, HURT RD, DAVIS LJ Jr, MORSE RM: Alcoholism in elderly persons: a study of the psychiatric and psychosocial features of 216 inpatients. Mayo Clin. Proc. (1988) 63(8):761-768.
62. ABRAMS RC, ALEXOPULUS GS: Substance abuse in the elderly: alcohol and prescription drugs. Hosp. Community Psychiatry (1987) 38:1285-1287.
63. DE LAS CUEVAS C, SANZ E, DE LAFUENTE JA et al.: The severity of dependence scale (SDS) as a screening test for benzodiazepine dependence: SDS validation study. Addiction (2000) 95:245-250.
64. PINSKER H, SULJAGA-PETCHEL K: Use of benzodiazepines in primary-care geriatric patients. J. Am. Geriatr. Soc. (1984) 32(8):595-597.
65. RIFKIN A, DODDI S, KARAJGI B, HASAN N, ALVAREZ L: Benzodiazepine use and abuse by patients at outpatient clinics. Am. J. Psychiatry (1989) 146(10):1131-1132.
66. HOLROYD S, DURYEE JJ: Characteristics of persons utilizing a geriatric psychiatry outpatient clinic. J. Geriatr. Psychiatry Neurol. (1997) 10(4):136-141.
67. WHITCUP SM, MILLER F: Unrecognized drug dependence in psychiatrically hospitalized elderly patients. J. Am. Geriatr. Soc. (1987) 35(4):297-310.
68. CLARK RE, XIE H, BRUNETTE MF: Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J. Clin. Psychiatry (2004) 65(2):151-155.
69. AMERICAN PSYCHIATRIC ASSOCIATION TASK FORCE ON BENZODIAZEPINE DEPENDENCY: Benzodiazepine dependence, toxicity and abuse. American Psychiatric Association, Washington DC, USA (1990):16.
70. BUSTO U, SELLERS E, NARANJO C, CAPPELL H, SANCHEZ-CRAIG M, SYKORA K: Withdrawal reaction after long term therapeutic use of benzodiazepines. N. Engl. J. Med. (1986) 315:854-859.
71. PETROVIC M, PEVERNAGIE D, VAN DEN NOORTGATE N, MARIMAN A, MICHIELSEN W, AFSCHRIFT M: A programme for short term withdrawal from benzodiazepines in geriatric hospital inpatients: success rate and effect on steep quality. Int. J. Geriatr. Psychiatry (1999) 14(9):754-760.
72. FOY A, DRINKWATER V, MARCH S, MEARRICK P: Confusion after admission to hospital in elderly patients using benzodiazepines. Br. Med. J. (Clin. Res. Ed.) (1986) 293(6554):1072.
73. SCHWEIZER EE, CASE WG, RICKELS K: Benzodiazepine dependence and withdrawal in elderly patients. Am. J. Psychiatry (1989) 146(4):1242-1243.
74. BOGUNOVIC OJ, GREENFIELD SE: Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr. Serv. (2004) 55(3):233-235.
75. BRYMER C, RUSNELL I: Reducing substance dependence in elderly people: the side effects program. Can. J. Clin. Pharmacol. (2000) 7(3):161-166.